Paratek Pharmaceuticals Agrees To Be Taken Private By Gurnet Point And Novo Holdings For $462M
Portfolio Pulse from Akanksha Bakshi
Paratek Pharmaceuticals has agreed to be acquired by Gurnet Point Capital and Novo Holdings for $462 million. The transaction includes debt financing of $175 million provided by Oaktree Capital Management and is expected to close in Q3 2023.
June 06, 2023 | 4:42 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Paratek Pharmaceuticals' stock price is likely to be impacted by the acquisition agreement with Gurnet Point Capital and Novo Holdings for $462 million.
The acquisition agreement directly involves Paratek Pharmaceuticals and is valued at a significant amount of $462 million. This news is highly relevant and important for investors in the company, and the stock price is likely to be impacted positively in the short term as the shares are trading higher by 13.2% at $2.22.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100